Diabetic Eye Screening for the Masses: Are We Ready for Autonomous AI?
On-Demand Webinar
![](https://www.visioncareprofessional.com/digital/eyenuk/1/eyenuk.png)
Diabetic Eye Screening for the Masses:
Are We Ready for Autonomous AI?
In this webinar, learn how the new EyeArt® Autonomous AI system is transforming the management of Diabetic Retinopathy (DR):
- Detection of More than Mild and Vision Threatening DR with the EyeArt Autonomous AI System
- Results from the EyeArt System Prospective, Multi-Center Pivotal Clinical Trial
- A University Health System's Vision in Using AI Technology to Manage Screening and Treatment of DR and Other Eye Diseases
Speakers:
![](/media/bl2okn41/sadda-yello.png)
SriniVas R. Sadda, MD,
President and Chief Scientific Officer, Doheny Eye Institute Chair of Ophthalmology, UCLA Geffen School of Medicine
![](/media/m0cdzwuc/lim-yellow.png)
Jennifer I. Lim, MD,
Vice Chair in Ophthalmology and Director of the Retina Service, University of Illinois at Chicago
![](/media/jxid3ria/henderer-yellow.png)
Jeffrey D. Henderer, MD,
Chair, Department of Ophthalmology, Lewis Katz School of Medicine at Temple University